Award

Provision of Human Challenge Studies

BUSINESS ENERGY AND INDUSTRIAL STRATEGY

This public procurement record has 2 releases in its history.

AwardUpdate

14 May 2021 at 15:07

Award Notice
Award

21 Jan 2021 at 14:57

Award Notice
Summary of the contracting process

The Business Energy and Industrial Strategy has recently completed a procurement process titled "Provision of Human Challenge Studies." This initiative falls under the category of research and experimental development services, valued at £46,132,758, located in the United Kingdom. The procurement was conducted as a direct method through a single tender action below the threshold. The tender period concluded on 16th October 2020, with the contract having commenced on 19th October 2020, and is set to run until 9th October 2024.

This tender presents significant opportunities for businesses engaged in research, particularly those specialising in clinical trials, vaccine development, and virology. Companies capable of conducting human challenge studies or those involved in the production of good manufacturing practice (GMP) virus would be well-positioned to compete. The focused nature of this contract highlights a need for specialised expertise, making it critical for firms with relevant experience and technical capabilities to respond to future similar tenders to enhance their business exposure and growth.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Provision of Human Challenge Studies

Notice Description

Virus manufacture and supply: Requirement for the manufacture and release of the Challenge Virus in accordance with GMP for use in the Human Virus Characterisation Study and Human Challenge Study. Human virus characterisation study: Provide the Human Virus Characterisation Study in accordance with the Protocol, GCP, GLP and all appropriate regulatory, legal, ethics and HSE requirements Optional services - Human vaccine challenge study: Reserve the first three (3) study slots for the Authority to assess the efficacy of potential vaccine candidates in Human Vaccine Challenge Studies

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-d69bbce2-39ba-4b4a-9de2-8c57cc281609
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/9d8fe3bd-b304-40d4-a383-beb4b630c0b9
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Direct
Procurement Method Details
Single tender action (below threshold)
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

73 - Research and development services and related consultancy services

CPV Codes

73100000 - Research and experimental development services

Notice Value(s)

Tender Value
£16,331,538 £10M-£100M
Lots Value
Not specified
Awards Value
£16,331,538 £10M-£100M
Contracts Value
Not specified

Notice Dates

Publication Date
14 May 20214 years ago
Submission Deadline
16 Oct 2020Expired
Future Notice Date
Not specified
Award Date
18 Oct 20205 years ago
Contract Period
18 Oct 2020 - 9 Oct 2024 3-4 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
BUSINESS ENERGY AND INDUSTRIAL STRATEGY
Contact Name
Not specified
Contact Email
vtfcontracts@beis.gov.uk
Contact Phone
Not specified

Buyer Location

Locality
LONDON
Postcode
SW1H 0ET
Post Town
South West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI35 Westminster and City of London
Delivery Location
Not specified
Local Authority
Westminster
Electoral Ward
St James's
Westminster Constituency
Cities of London and Westminster

Supplier Information

Number of Suppliers
1
Supplier Name

HVIVO SERVICES

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-d69bbce2-39ba-4b4a-9de2-8c57cc281609-2021-05-14T16:07:49+01:00",
    "date": "2021-05-14T16:07:49+01:00",
    "ocid": "ocds-b5fd17-d69bbce2-39ba-4b4a-9de2-8c57cc281609",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "4674/10/2020",
        "title": "Provision of Human Challenge Studies",
        "description": "Virus manufacture and supply: Requirement for the manufacture and release of the Challenge Virus in accordance with GMP for use in the Human Virus Characterisation Study and Human Challenge Study. Human virus characterisation study: Provide the Human Virus Characterisation Study in accordance with the Protocol, GCP, GLP and all appropriate regulatory, legal, ethics and HSE requirements Optional services - Human vaccine challenge study: Reserve the first three (3) study slots for the Authority to assess the efficacy of potential vaccine candidates in Human Vaccine Challenge Studies",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "73100000",
            "description": "Research and experimental development services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "United Kingdom"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 16331538,
            "currency": "GBP"
        },
        "procurementMethod": "direct",
        "procurementMethodDetails": "Single tender action (below threshold)",
        "tenderPeriod": {
            "endDate": "2020-10-16T12:00:00+01:00"
        },
        "contractPeriod": {
            "startDate": "2020-10-19T00:00:00+01:00",
            "endDate": "2024-10-09T23:59:59+01:00"
        },
        "suitability": {
            "sme": false,
            "vcse": false
        },
        "mainProcurementCategory": "services"
    },
    "parties": [
        {
            "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/57hG7nME",
            "name": "Business Energy and Industrial Strategy",
            "identifier": {
                "legalName": "Business Energy and Industrial Strategy",
                "scheme": "GB-SRS",
                "id": "sid4gov.cabinetoffice.gov.uk/57hG7nME"
            },
            "address": {
                "streetAddress": "1 Victoria Street",
                "locality": "London",
                "postalCode": "SW1H0ET",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "VTFContracts@beis.gov.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-COH-02326557",
            "name": "HVIVO SERVICES LIMITED",
            "identifier": {
                "legalName": "HVIVO SERVICES LIMITED",
                "scheme": "GB-COH",
                "id": "02326557"
            },
            "address": {
                "streetAddress": "42 NEW ROAD E1 2AX GB"
            },
            "details": {
                "scale": "large",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/57hG7nME",
        "name": "Business Energy and Industrial Strategy"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-d69bbce2-39ba-4b4a-9de2-8c57cc281609-1",
            "status": "active",
            "date": "2020-10-19T00:00:00+01:00",
            "datePublished": "2021-01-21T14:57:47Z",
            "value": {
                "amount": 16331538,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-COH-02326557",
                    "name": "HVIVO SERVICES LIMITED"
                }
            ],
            "contractPeriod": {
                "startDate": "2020-10-19T00:00:00+01:00",
                "endDate": "2024-10-09T23:59:59+01:00"
            },
            "description": "This contract is for research and experimental development services. The benefits of the contract do not accrue exclusively to HMG but to the scientific and academic communities more widely. It is excluded from the requirements of the Public Contracts Regulations 2015 by application of regulation 14. The contractor was identified by a selection process that concluded that hVIVO was the only contractor capable of delivering the authority's requirements in the time required. The authority considered and approached a number of alternative suppliers; however, none indicated that it had taken or had any intention to take any steps towards developing the capability to deliver human challenge studies relating to SARS-CoV-2 in the near future. The closest alternative to hVIVO would delay the commencement of the characterisation study by a period of between 6 and 12 months, potentially prolonging the public health and economic consequences of the pandemic. Having conducted technical and market analysis, the authority concluded that hVIVO is the only potential provider technically capable to deliver good manufacturing practice (GMP) virus, a characterisation study of that virus and the subsequent vaccine challenge studies with the required number of participants within the Authority's required timeframe. hVIVO is the only company to have publicly committed to conducting commercial human challenge studies relating to SARS-CoV-2 and the only organisation capable of delivering GMP virus in time for the characterisation study to commence in January 2021. The contracting authority requires the characterisation study to commence in January 2021 because the resultant vaccine challenge studies are a crucial element of its strategy to bring about an end to the public health and economic consequences of the Covid-19 pandemic. January 2021 is the earliest date that a suitable facility and approved study protocol will be available to commence a characterisation study in order to enable vaccine challenge studies to commence in May 2021. It is an essential requirement, therefore, that the contractor is capable of delivering GMP virus and delivering a characterisation study before then.",
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/9d8fe3bd-b304-40d4-a383-beb4b630c0b9",
                    "datePublished": "2021-01-21T14:57:47Z",
                    "format": "text/html",
                    "language": "en",
                    "dateModified": "2021-05-14T16:07:49+01:00"
                },
                {
                    "id": "2",
                    "documentType": "contractSigned",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/SupplierAttachment/dd88ca23-06e4-43a3-b66b-90fe1c5b8ce6",
                    "format": "application/pdf"
                }
            ]
        }
    ]
}